Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

3518 ARTÍCULOS , VIENDO DEL 2311 AL 2325

A systematic review of biomarkers for disease progression in Alzheimer's disease

McGhee DJ, Ritchie CW, Thompson PA, Wright DE, Zajicek JP, Counsell CE.

PLoS One. 2014 Feb 18;9(2):e88854. doi: 10.1371/journal.pone.0088854. eCollection 2014.

Meta-analysis of peripheral blood apolipoprotein E levels in Alzheimer's disease

Wang C, Yu JT, Wang HF, Jiang T, Tan CC, Meng XF, Soares HD, Tan L.

PLoS One. 2014 Feb 18;9(2):e89041. doi: 10.1371/journal.pone.0089041. eCollection 2014.

Lipidomics of Alzheimer's disease

Touboul D, Gaudin M.

Bioanalysis. 2014 Feb;6(4):541-61. doi: 10.4155/bio.13.346.

Epigenetic dysregulation in Alzheimer's disease: cause or consequence?

van den Hove DL, Kenis G, Rutten BP.

Epigenomics. 2014 Feb;6(1):9-11. doi: 10.2217/epi.13.84.

Diffusion tensor imaging of white matter degeneration in Alzheimer's disease and mild cognitive impairment

Amlien IK, Fjell AM.

Neuroscience. 2014 Sep 12;276:206-15. doi: 10.1016/j.neuroscience.2014.02.017. Epub 2014 Feb 27.

Detection of retinal nerve fiber layer degeneration in patients with Alzheimer's disease using optical coherence tomography: searching new biomarkers

Bambo MP, Garcia-Martin E, Pinilla J, Herrero R, Satue M, Otin S, Fuertes I, Marques ML, Pablo LE.

Acta Ophthalmol. 2014 Nov;92(7):e581-2. doi: 10.1111/aos.12374. Epub 2014 Mar 4.

Harmonized diagnostic criteria for Alzheimer's disease: recommendations

Morris JC, Blennow K, Froelich L, Nordberg A, Soininen H, Waldemar G, Wahlund LO, Dubois B.

J Intern Med. 2014 Mar;275(3):204-13. doi: 10.1111/joim.12199.

Clinical trials and late-stage drug development for Alzheimer's disease: an appraisal from 1984 to 2014

Schneider LS, Mangialasche F, Andreasen N, Feldman H, Giacobini E, Jones R, Mantua V, Mecocci P, Pani L, Winblad B, Kivipelto M.

J Intern Med. 2014 Mar;275(3):251-83. doi: 10.1111/joim.12191.

Variance in the identification of microRNAs deregulated in Alzheimer's disease and possible role of lincRNAs in the pathology: the need of larger datasets

Lau P, Frigerio CS, De Strooper B.

Ageing Res Rev. 2014 Sep;17:43-53. doi: 10.1016/j.arr.2014.02.006. Epub 2014 Mar 4.

Plasma phospholipids identify antecedent memory impairment in older adults

Mapstone M, Cheema AK, Fiandaca MS, Zhong X, Mhyre TR, MacArthur LH, Hall WJ, Fisher SG, Peterson DR, Haley JM, Nazar MD, Rich SA, Berlau DJ, Peltz CB, Tan MT, Kawas CH, Federoff HJ.

Nat Med. 2014 Apr;20(4):415-8. doi: 10.1038/nm.3466. Epub 2014 Mar 9.

Additional use of Aβ₄₂/Aβ₄₀ ratio with cerebrospinal fluid biomarkers P-tau and Aβ₄₂ increases the level of evidence of Alzheimer's disease pathophysiological process in routine practice

Sauvée M, DidierLaurent G, Latarche C, Escanyé MC, Olivier JL, Malaplate-Armand C.

J Alzheimers Dis. 2014;41(2):377-86. doi: 10.3233/JAD-131838.

A case of inappropriate apolipoprotein e testing in Alzheimer's disease due to lack of an informed consent discussion

Furman CD, Earnshaw LA, Doukas DJ, Farrer LA, Friedland RP.

Am J Alzheimers Dis Other Demen. 2014 Nov;29(7):590-5. doi: 10.1177/1533317514525829. Epub 2014 Mar 10.

[Depression or Alzheimer-type dementia?]

Bystad M, Pettersen K, Grønli OK.

Tidsskr Nor Laegeforen. 2014 Mar 11;134(5):525-8. doi: 10.4045/tidsskr.13.0364. eCollection 2014 Mar 11.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias